SCHEMBL21364518

SCHEMBL21364518

N#Cc1ccccc1-c1ccc(-n2c3ccccc3c3cc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)ccc32)c(-c2cc(-n3c4ccccc4c4cc(-c5nc(-c6ccccc6)nc(-c6ccccc6)n5)ccc43)ccc2-c2nc(-c3ccccc3)nc(-c3ccccc3)n2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 1/20 0.39
TRPA1 O75762 1/20 0.35
CYP1A2 P05177 6/20 0.33
CYP3A4 P08684 6/20 0.33
ALDH1A1 P00352 5/20 0.33
HSD17B10 Q99714 4/20 0.33
HPGD P15428 4/20 0.33
MAPK1 P28482 3/20 0.33
CLK4 Q9HAZ1 3/20 0.33
LMNA P02545 3/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
USP2 O75604 2/20 0.32
CYP2D6 P10635 2/20 0.32
CYP2C19 P33261 2/20 0.32
CYP2C9 P11712 1/20 0.32
TSHR P16473 1/20 0.32
BLM P54132 1/20 0.32
ALOX5AP P20292 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21364821 0.97 NR3C1 (0.39) NR3C1TRPA1CYP1A2CYP3A4ALDH1A1
SCHEMBL21364819 0.97 NR3C1 (0.40) NR3C1TRPA1CYP1A2CYP3A4ALDH1A1
SCHEMBL21364523 0.97 NR3C1 (0.41) NR3C1TRPA1CYP1A2CYP3A4ALDH1A1
SCHEMBL22242970 0.94 NR3C1 (0.40) NR3C1TRPA1CYP1A2CYP3A4ALDH1A1
SCHEMBL21364822 0.94 NR3C1 (0.40) NR3C1TRPA1CYP1A2CYP3A4ALDH1A1
SCHEMBL23965885 0.94 NR3C1 (0.36) NR3C1TRPA1CYP1A2CYP3A4ALDH1A1
SCHEMBL22242992 0.94 NR3C1 (0.38) NR3C1TRPA1CYP1A2CYP3A4ALDH1A1
SCHEMBL21364502 0.94 NR3C1 (0.38) NR3C1TRPA1CYP1A2CYP3A4ALDH1A1
SCHEMBL21364690 0.93 NR3C1 (0.42) NR3C1TRPA1CYP1A2CYP3A4ALDH1A1
SCHEMBL21364692 0.93 NR3C1 (0.42) NR3C1TRPA1CYP1A2CYP3A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11161836-B2 Organic molecules for optoelectronic devices CYNORA GMBH (DE) 2021-11-02 US disclosed
US-20190284174-A1 ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2019-09-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190284174-A1 ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES OR10J3, OR51E2, OCIAD2 NR3C1 4626/4885TRPA1 35/4885CYP1A2 540/4885
US-11161836-B2 Organic molecules for optoelectronic devices OR10J3, OR51E2, OCIAD2 NR3C1 4626/4885TRPA1 35/4885CYP1A2 540/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.